Search

Your search keyword '"Sood, Anil K."' showing total 77 results

Search Constraints

Start Over You searched for: Author "Sood, Anil K." Remove constraint Author: "Sood, Anil K." Publisher wiley Remove constraint Publisher: wiley
77 results on '"Sood, Anil K."'

Search Results

2. Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum‐resistant ovarian cancer

3. Clinical implications of tumor‐based next‐generation sequencing in high‐grade epithelial ovarian cancer

8. Pan‐cancer clinical and molecular analysis of racial disparities

9. Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53‐altered tumors

10. Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference

11. Life stress as a risk factor for sustained anxiety and cortisol dysregulation during the first year of survivorship in ovarian cancer

13. Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma

14. MIIPhaploinsufficiency induces chromosomal instability and promotes tumour progression in colorectal cancer

18. Clinical impact of selective and nonselective beta‐blockers on survival in patients with ovarian cancer

19. Eudaimonic well-being and tumor norepinephrine in patients with epithelial ovarian cancer

20. MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer

21. BRCA2 inhibition enhances cisplatin‐mediated alterations in tumor cell proliferation, metabolism, and metastasis

24. Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis

25. Significance of lymphovascular space invasion in epithelial ovarian cancer

26. Reclassification of serous ovarian carcinoma by a 2-tier system

27. Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer

30. Plasma cell-free DNA in ovarian cancer

31. Pelvic fractures after radiotherapy for cervical cancer

34. Glucose as a prognostic factor in ovarian carcinoma

35. Functional significance of VEGFR-2 on ovarian cancer cells

45. Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer

46. Primary ovarian sarcoma

49. Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer.

50. Pan-cancer clinical and molecular analysis of racial disparities.

Catalog

Books, media, physical & digital resources